iBio, Inc. Common Stock (NASDAQ: IBIO) last traded at $0.781, down 0.13% on the session. The quote above updates while this page is open; the figures below are drawn from iBio, Inc. Common Stock’s own filings and are restated only when a new one is published.
iBio, Inc. Common Stock trades on NASDAQ under the ticker IBIO. Its market capitalisation is $50.21 million.
Valuation measures for iBio, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $50.21M |
|---|---|
| Enterprise value | $7.21M |
| Price / sales | 167.37 |
| Price / book | 0.59 |
| Beta | 2.06 |
Trailing-twelve-month figures tagged in iBio, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $300.0K |
|---|---|
| Net income (TTM) | -$33.04M |
| Operating margin | -11713.67% |
| Return on equity | -38.55% |
| Cash | $56.40M |
Range and volume for IBIO over the past 52 weeks.
| 52-week high | $3.82 |
|---|---|
| 52-week low | $0.730 |
| Volume | 1.43M |
| Average volume | 744.3K |
| Previous close | $0.782 |
Invest a chosen dollar amount in iBio, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell IBIO.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.